Prognostic Power of the VEXUS Score in Septic Shock: Effectiveness in Mortality Prediction (NCT07124741) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Prognostic Power of the VEXUS Score in Septic Shock: Effectiveness in Mortality Prediction
100 participantsStarted 2026-03-30
Plain-language summary
This study aims to evaluate the prognostic power of the VEXUS Score in predicting mortality among patients with septic shock in intensive care units.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age\>18
* Patients monitored for septic shock in intensive care unit
* Signed informed consent
Exclusion Criteria:
* Age \<18
* Severe obesity precluding adequate ultrasonographic imaging.
* Patients in whom venous structures cannot be clearly assessed via ultrasonography due to anatomical or technical reasons (e.g., adhesions following abdominal surgery).
* Patients receiving dialysis due to chronic kidney disease or initiating dialysis for acute kidney failure.
* Chronic heart failure.
* Patients with advanced valvular insufficiency or advanced pulmonary hypertension.
* Patients with portal hypertension or advanced-stage liver cirrhosis.
* Presence of acute or chronic thrombosis in the inferior vena cava or other venous structures within the scoring area.
* Refusal to participate
What they're measuring
1
28-day intensive care unit mortality in relation to VEXUS score
Timeframe: Up to 28 days following intensive care unit admission.